Search

Hutchison China MediTech Ltd ADR

Fechado

SetorSaúde

13.52 0.52

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.13

Máximo

13.57

Indicadores-chave

By Trading Economics

Rendimento

-8.9M

-8M

Vendas

3.7M

139M

P/E

Médio do Setor

135.5

48.735

Margem de lucro

-5.724

Funcionários

1,790

EBITDA

18M

4M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+23.05% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

443M

2.4B

Abertura anterior

13

Fecho anterior

13.52

Hutchison China MediTech Ltd ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de out. de 2026, 23:51 UTC

News

Etsy Inc shares are trading lower in after-market hours despite Payoneer's renewal of its partnership through 2029 to support international sellers.

13 de out. de 2026, 23:51 UTC

News

DraftKings Inc shares are trading lower in after-market hours as the FTC launches a preliminary inquiry into potential deceptive practices in the sports betting industry.

13 de out. de 2026, 23:51 UTC

News

UBS maintains a Buy rating on Apollo Global Management while lowering its price target to $163, citing a 17.36% average annual return over 15 years.

13 de out. de 2026, 23:41 UTC

News

Citigroup maintains a Neutral rating on Phillips 66 and raises its price target to $297, reflecting ongoing confidence in the company's performance.

13 de out. de 2026, 23:41 UTC

News

Shares of Wayfair Inc are trading lower in after-market hours following the announcement of an expanded partnership with Klarna Group, offering 0% APR financing.

13 de out. de 2026, 23:41 UTC

News

Cheniere Energy Inc shares declined modestly in after-market trading amid rising LNG prices in Asia and concerns over low gas storage levels in Europe.

13 de out. de 2026, 23:36 UTC

News

L3Harris Technologies partners with Divergent Technologies to enhance production capabilities for its Wolf Pack munitions, utilizing additive manufacturing for battlefield adaptability.

13 de out. de 2026, 23:36 UTC

News

PG&E Corp prepares for potential Public Safety Power Shutoffs affecting 70k customers across 29 counties due to high winds and dry conditions.

13 de out. de 2026, 23:31 UTC

News

B&G Foods Inc sells its B&M and Joan of Arc brands to McCall Farms, aiming to use proceeds for long-term debt repayment.

13 de out. de 2026, 23:26 UTC

News
Correlated Moves

ServiceNow is reportedly in early discussions to acquire AI startup Decagon, which was valued at $4.5 billion earlier this year.

13 de out. de 2026, 23:26 UTC

News

Leidos Holdings awarded a $317.99 million contract by the Defense Health Agency for MHS Genesis system reintegration and software services, running from 2026 to 2028.

13 de out. de 2026, 23:16 UTC

News

Citigroup maintains Buy rating on Tractor Supply Co and raises price target to $38, providing a bullish outlook for the company.

13 de out. de 2026, 23:16 UTC

News
Correlated Moves

Welltower to sell 30 leased communities to Brookdale Senior Living for $290 million, reducing Brookdale's annual cash rent payments by about $17.8 million.

13 de out. de 2026, 23:16 UTC

News

A securities class action lawsuit has been filed against DICK'S Sporting Goods, alleging misleading statements about financial performance and inventory management.

13 de out. de 2026, 23:11 UTC

News
Social Media

Microsoft directs senior leaders to cut Azure costs by 20%, amid ongoing restructuring, according to a report from The Information.

13 de out. de 2026, 23:11 UTC

News
Correlated Moves

The USD/SEK is modestly lower following the NFIB Small Business Optimism Index for September, which came in at 97.9, below the forecast of 98.1.

13 de out. de 2026, 23:06 UTC

News

Cirrus Logic withdraws its acquisition proposals for Synaptics, confirming its role as "Party A" in the pending merger with ON Semiconductor.

13 de out. de 2026, 23:06 UTC

News

Interactive Brokers Group Inc shares are declining in after-market trading, despite a 35% year-over-year increase in client accounts and the launch of Ethereum staking services.

13 de out. de 2026, 23:06 UTC

News

NetApp Inc shares declined during after-market hours on Tuesday, though they remained above their lowest point reached after the regular session ended.

13 de out. de 2026, 23:06 UTC

Correlated Moves
News

Wells Fargo shares are little changed in after-market trading, having retraced from earlier gains despite Citigroup's higher performance following its earnings results.

13 de out. de 2026, 23:06 UTC

News

UBS reaffirms Buy rating on KKR & Co Inc, lowering price target to $122; KKR Fs Income Trust secures up to $250M loan agreement.

13 de out. de 2026, 23:02 UTC

Macro News
News

Bitcoin advances as a UK High Court ruling permits retention of 61k seized BTC, while Russia's Sberbank is authorized to facilitate Bitcoin transactions.

13 de out. de 2026, 23:01 UTC

News

Cisco Systems Inc shares declined in after-market trading, with a put/call ratio of 0.66 indicating a moderately bearish outlook among traders.

13 de out. de 2026, 23:01 UTC

News

Rivian Automotive appoints Doug Field as president of Mind Robotics, focusing on AI and robotics in manufacturing, with the spinoff securing over $1 billion for development.

13 de out. de 2026, 23:01 UTC

News

Quarterly cash dividend raised to $0.26; 650k shares repurchased.

13 de out. de 2026, 23:01 UTC

News

USD/ZAR is trading modestly lower, influenced by the U.S. NFIB Small Business Optimism index, which came in at 97.9, below the forecast of 98.1.

13 de out. de 2026, 23:01 UTC

News
Correlated Moves

USD/NOK is modestly lower following the release of U.S. NFIB small business optimism data for September, which came in at 97.9, below expectations.

13 de out. de 2026, 23:01 UTC

News

Energy Fuels Inc filed a prospectus to offer common shares of up to $500 million to raise capital.

13 de out. de 2026, 23:01 UTC

News
Social Media

GameStop shares advanced after CEO Ryan Cohen disclosed the purchase of 844.13k shares, increasing his stake to approximately 9.1%, totaling over $22 million.

13 de out. de 2026, 23:01 UTC

Event
Social Media
News

AZZ Inc. reported fiscal Q2 sales of $486.9 million and adjusted EPS of $2.00, raising its fiscal year 2027 guidance for EPS and sales.

Comparação entre Pares

Variação de preço

Hutchison China MediTech Ltd ADR Previsão

Preço-alvo

By TipRanks

23.05% parte superior

Previsão para 12 meses

Média 16.833 USD  23.05%

Máximo 18.5 USD

Mínimo 14 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Hutchison China MediTech Ltd ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat